With the COVID-19 pandemic entering its second year, we have moved beyond a time of immediate repercussions to considerations for the longer term. How can we address this changing landscape?
The COVID-19 pandemic spurred several organizations and companies around the world to try and find a working vaccine candidate within a relatively short period of time. On November 9, 2020, Pfizer and BioNTech [Pfizer Press Release] announced their vaccine candidate had achieved a success rate of 90% in their first efficacy analysis.
Managers or Directors of Quality Assurance face many challenges in their important role. They must design, implement, and maintain GxP quality management systems, while ensuring that regulatory compliance requirements are met.